Kamboh M I, Mehdi H
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA.
Lupus. 1998;7 Suppl 2:S10-3. doi: 10.1177/096120339800700203.
Apolipoprotein H (apoH; also known as beta2-glycoprotein I), is an essential cofactor for the binding of certain antiphospholipid antibodies (APA) to anionic phospholipid. The gene coding for apoH is polymorphic, with the occurrence of several common alleles in the general population. This genetically determined variation can effect the binding of apoH to anionic phospholipids and consequently the production of APA. Our group has identified two common mutations at codons 306 (Cys-->Gly) and 316 (Trp-->Ser) in the fifth domain of apoH which affect the binding of apoH to anionic phospholipids (phosphatidylserine or cardiolipin). ApoH from serum samples homozygous for each of these mutations or compound heterozygotes for both mutations showed no binding with anionic phospholipids on ELISA. In vitro mutagenesis and transient expression of these mutations in COS-1 cells followed by cardiolipin binding studies confirmed that Gly306 and Ser316 are causative mutations. Our data indicate that the fifth domain of apoH is essential for anionic phospholipid binding and genetically determined variation in this domain can affect the production of apoH-dependent APA.
载脂蛋白H(apoH;也称为β2-糖蛋白I)是某些抗磷脂抗体(APA)与阴离子磷脂结合的必需辅助因子。编码apoH的基因具有多态性,在普通人群中存在几种常见的等位基因。这种由基因决定的变异会影响apoH与阴离子磷脂的结合,进而影响APA的产生。我们的研究小组在apoH的第五结构域中鉴定出密码子306(半胱氨酸→甘氨酸)和316(色氨酸→丝氨酸)处的两个常见突变,这些突变会影响apoH与阴离子磷脂(磷脂酰丝氨酸或心磷脂)的结合。来自这些突变纯合子血清样本或两种突变的复合杂合子的apoH在ELISA上与阴离子磷脂无结合。在COS-1细胞中对这些突变进行体外诱变和瞬时表达,随后进行心磷脂结合研究,证实甘氨酸306和丝氨酸316是致病突变。我们的数据表明,apoH的第五结构域对于阴离子磷脂结合至关重要,该结构域中由基因决定的变异会影响依赖apoH的APA的产生。